Basil Health Ventures is a Cambridge-based venture fund investing $280M+ across digital health, biotech, and medical devices. Founded in 2014, the firm leads Series A rounds — typically $5–25M — and stays invested through clinical validation, regulatory clearance, and beyond. We back 34 active portfolio companies, with 12 exits and 3 IPOs since inception.
Our investment thesis has never changed: the best healthcare founders understand both the biology and the system. Clinicians who trained at teaching hospitals. Researchers who ran their own labs. Engineers who built devices that ended up in operating rooms. We back them when the risk is real and the runway is long — not when the headlines make it easy.
Over twelve years we've backed companies across digital health, biotech, and medical devices. Some are public. Some were acquired. Most are still in the field, grinding through the long middle of the healthcare innovation cycle. We stay with them through all of it. That's what it means to be a genuine partner in this space.
"We back founders who spent their careers in the clinic before they ever wrote a line of code."Dr. Priya Sharma, Managing Partner
